Long‐term survival of an advanced colorectal cancer patient treated with Regorafenib: Case report and literature review

Long‐term survival of an advanced colorectal cancer patient treated with Regorafenib: Case report and literature review

Abstract Two phase 3 trials reported a prolonged survival in the third‐line setting of colorectal cancer patients treated with regorafenib with the longest duration of treatment of 16 months. Herein, we reported a unique case of a patient refractory to conventional chemotherapy who showed a prolonge...

Full description

Bibliographic Details
Main Authors: Oronzo Brunetti, Angela Calabrese, Loredana Palermo, Antonio Giovanni Solimando, Antonella Argentiero
Format: Article
Language:English
Published: Wiley 2019-12-01
Series:Clinical Case Reports
Subjects:
colorectal cancer
long‐term survival
regorafenib
Online Access:https://doi.org/10.1002/ccr3.2496

Similar Items

Similar Items